摘要
血浆可溶性血栓调节蛋白(sTM)、可溶性内皮细胞蛋白C受体(sEPCR)和游离组织因子途径抑制物(fTFPI)是近年来广泛采用的凝血系统检验项目。sTM、sEPCR和fTFPI参与了多种疾病,从微血管病变到器质性病变进程,已成为危重病患者出现严重合并症的早期标志物,定量检测上述物质的动态变化,可及时反映机体的病理过程、转归及预后。
出处
《国际检验医学杂志》
CAS
2008年第4期361-363,366,共4页
International Journal of Laboratory Medicine
参考文献16
-
1Lu XL, Cai JT, Lu XG, et al. Plasma level of thrombomodulin is an early indication of pancreatic necrosis in patients with acute pancreatitis [J]. Intern Med, 2007, 46(8): 441-445. 被引量：1
-
2Bouton MC, Venisse L, Richard B, et al. Protease nexin-1 interacts with thrombomodulin and modulates its anticoagulant effect [J]. CircRes, 2007, 100(8): 1174-1181. 被引量：1
-
3Abdel-Gader AM, Al-Mishari AA, Awadalla SA, et al. Total and free tissue factor pathway inhibitor in pregnancy hypertension [J]. Int J Gynaecol Obstet,2006,95(3): 248-253. 被引量：1
-
4Morange PE,Blankenberg S,Alessi MC,et al. Prognostic value of plasma tissue factor and tissue factor pathway inhibitor for cardiovascular death in patients with coronary artery disease: the AtheroGene study[J]. J Thromb Haemost, 2007,5 (3):475-482. 被引量：1
-
5Adams MJ, Thorn J, Hankey GJ, et al.The tissue factor pathway in ischemic stroke [J]. Blood Coagul Fibrinolysis, 2006,17(7):527-532. 被引量：1
-
6Al-Mugeiren MM, Abdel-Gader AG, Al-Rasheed SA, et al. Tissue factor pathway inhibitor in childhood nephrotic syndrome [J]. Pediatr Nephrol, 2006, 21(6): 771-777. 被引量：1
-
7Wojtkielewicz K, Urban M, Peczynska J, et al. Czy rozpuszczalna trombomodulina (STM) jest markerem uszkodzenia srodblonka naczyn u dzieci i mlodziezy z nadcisnieniem temiczym[Is soluble thrombomodulin a molecular marker of endothelial cell injury in children and adolescents with arterial hypertension] [J]? Med W. ieku Rozwoj, 2006, 10(3 Pt 2) : 893-902. 被引量：1
-
8Gumus K, Kadayifcilar S, Eldem B, et al. Is elevated level of soluble endothelial protein C receptor a new risk factor for retinal vein occlusion [J]? Clin Experiment Ophthalmol, 2006, 34(4): 305-311. 被引量：1
-
9Kendirli T, Ciftci E, Ince E, et al. Homozygous 23-bp insertion of endothelial protein c receptor gene in a child with fatal sepsis [J]. Pediatr Hematol Oncol, 2007, 24(3) : 199-204. 被引量：1
-
10王鸿利.血栓与止血检测进展[J].微循环学杂志,2007,17(1):4-7. 被引量：2
二级参考文献11
-
1王传新,牛爱军,卢振铎,杨晓静,王立水,邹雄.特发性血小板减少性紫癜患者血小板微颗粒检测与抗血小板膜表面糖蛋白CD62P的相关性[J].中华医学杂志,2003,83(21):1918-1919. 被引量：3
-
2阮长耿.血小板与血栓性疾病[J].中华医学杂志,2003,83:1-3. 被引量：2
-
3Li N,Goodall AH,Hjemdahl P.A sensitive flow cytometric assay for circulating platelet-leucocyte aggregates.Br J Haematol,1997,99:808～816. 被引量：1
-
4Toh CH,Giles AR.Waveform analysis of clotting test optical profiles in the diagnosis and management of disseminated intravascular coagulation(DIC).Clin Lab Haem,2002,24:321～ 327. 被引量：1
-
5Bauma BN,Marx PF,Mosnier LO,et al.Thrombin-activatable fibrinolysis inhibitor (TAFI,plasma procarboxypeptidase B,procarboxypeptidase R,procarboxypeptidase U).Thromb Res,2001,101(5):329～354. 被引量：1
-
6Wang W,Boffa MB,Bjazar L,et al.A study of the mechanism of inhibition of fibrinolysis by activated thrombin-activable fibrinolysis inhibitor.J Biol Chem,1998,273 (42):27 176～27 181. 被引量：1
-
7Kurosawa S,Stearns-Kurosawa DJ,Carson CW,et al.Plasma levels of endothelial cell protein C receptor are elevated in patients with sepsis and systemic lupus erythematosus:lack of correlation with thrombomodulin suggests involvement of different pathological processes.Blood,1998,91(2):725～727. 被引量：1
-
8Vasse M,Guegan-Massardier E,Borg JY,et al.Frequency of protein Z deficiency in patients with ischaemic stroke.Lancet,2001,357(9 260):933～934. 被引量：1
-
9Gigarel N,Frydman N,Burlet P,et al.Single cell co-amplification of polymorphic markers for the indirect preimplantation genetic diagnosis of hemophilia A,X-linked adreno leukodystrophy,X-linked hydrocephalus and incontinentia pigmenti loci on Xq28.Hum Genet,2004,114(3):298～305. 被引量：1
-
10Santalo J,Grossmann M,Gimenez C,et al.The decision to cancel a preimplantation genetic diagnosis cycle.Prenat Diagn,2000,20:564～566. 被引量：1
同被引文献3
-
1杨韵宏,向小平,谢圣兰,曹玲.高脂血症患者血清凝血酶调节蛋白水平的检测[J].中国全科医学,2004,7(23):1780-1781. 被引量：1
-
2李萍.原发性肝癌患者血浆血栓调节蛋白测定的临床意义[J].国际检验医学杂志,2009,30(5):494-494. 被引量：4
-
3谭莹,张吉才,李文斌.糖化血红蛋白及血栓前体蛋白检测对急性缺血性脑血管病患者的临床价值探讨[J].现代中西医结合杂志,2013,22(19):2145-2146. 被引量：12
-
1张近波,张小乐,董美平,许国斌,王文龙,董志兵.创伤后蛋白C水平的早期减少使VAP的风险增加[J].中华医院感染学杂志,2011,21(19):3978-3980.
-
2李益华,张荣生,等.脑血管病患者血浆可溶性血栓调节蛋白检测的临床应用[J].中国检验医学与临床,2002,3(3):130-130.
-
3钱定良,闫绍荣,刘凌云.可溶性内皮细胞蛋白C受体和可溶性血栓调节蛋白在2型糖尿病诊疗中的临床意义[J].检验医学,2017,32(3):208-209. 被引量：3
-
4褚伟强,卢国元,赵里曼.可溶性内皮细胞蛋白C受体及血栓调节蛋白在肾病综合症患者血浆中的变化及临床意义[J].中国血液流变学杂志,2011,21(4):720-722. 被引量：5
-
5燕丽娜.系统化出院指导对哮喘病人预后的临床观察[J].今日健康,2014,13(8):93-93.
-
6顾本彬.护理工作中监测生命体征的意义[J].黑龙江医学,2003,27(10):777-778.
-
7王维明,姚印刚.肝癌患者血浆可溶性血栓调节蛋白及蛋白C的检测及其临床意义[J].现代检验医学杂志,2008,23(2):123-123. 被引量：2
-
8潘景业,张近波,吴河水,王晓蓉,陈洁,马继红,姚震亚.失血性休克大鼠内皮细胞蛋白C受体表达的研究[J].山东医药,2008,48(45):33-34.
-
9王继贵.心肌损伤的新标志物[J].临床检验信息导报,1999,6(3):71-73. 被引量：7
-
10陈彤,范玉平,陈宇翔,吴俊渊,张秀琳,杨屹.hsCRP、sEPCR与动静脉内瘘血栓形成的关系[J].标记免疫分析与临床,2015,22(4):294-297. 被引量：7
